Literature DB >> 32328617

[Role of adrenergic receptors in tumorigenesis and development of glioma].

Ye He1, Yu-Ge Zhu2, Wei-Zhu Liu3, Wen-Hua Zhang3, Bing-Xing Pan3, Ping Hu4.   

Abstract

Gliomas are malignant tumors with strong invasiveness. The current treatment strategy is surgical treatment assisted by a variety of radiotherapies, chemotherapies and immunotherapies. However, the curative efficacy is limited. Adrenergic receptor (AR) is an important stress hormone receptor, which is highly involved in the regulation of the tumorigenesis and progression of various tumors by activating different downstream signal transduction pathways. Recent studies have shown that AR is dysregulated in glioma cells and tissues, and plays an important role in a series of biological behaviors such as tumorigenesis, invasion and metastasis of glioma. This article reviews the research progress of AR in the field of glioma in recent years, which provides a theoretical basis for the prevention and treatment of glioma targeting the AR.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32328617

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  1 in total

1.  Clinical value of propranolol combined with oxaliplatin and tigio in concurrent chemoradiotherapy for locally advanced gastric cancer.

Authors:  Yong Chen; Yu Chen; Zhibang Wang; He Li; Yongqi Wang
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.